Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Vitamin D Deficiency D014808 13 associated lipids
Critical Illness D016638 13 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Anemia D000740 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Vadasz D et al. Intravenous iron sucrose for restless legs syndrome in pregnant women with low serum ferritin. 2013 Sleep Med. pmid:24012019
Grim K et al. Treatment of childhood-onset restless legs syndrome and periodic limb movement disorder using intravenous iron sucrose. 2013 Sleep Med. pmid:23993871
Earley CJ et al. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. 2009 Sleep Med. pmid:18280205
Mercuriali F Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. 1996 Semin. Hematol. pmid:8723574
Mercuriali F Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia. 1996 Semin. Hematol. pmid:8723576
Tryba M Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery. 1996 Semin. Hematol. pmid:8723577
Folkert VW Safety of high doses of non-dextran irons. 2003 May-Jun Semin Dial pmid:12753696
Fishbane S and Kowalski EA The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. 2000 Nov-Dec Semin Dial pmid:11130261
Sandstad O et al. D-glucaric acid in common duct bile and relation to choledocholithiasis. 2002 Scand. J. Gastroenterol. pmid:11989842
Erichsen K et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. 2005 Scand. J. Gastroenterol. pmid:16165718
Ho YD and Ho KJ Biliary D-glucaric acid: its quantitation and preventive role in gallstone formation. 1990 Scand. J. Gastroenterol. pmid:2359994
Lindgren S et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. 2009 Scand. J. Gastroenterol. pmid:19330567
Sandstad O et al. Urinary D-glucaric acid, a marker substance for microsomal enzyme induction. Methodological aspects, responses to alcohol and findings in workers exposed to toluene. 1993 Scand. J. Clin. Lab. Invest. pmid:8378735
Hotz P et al. Study of some hepatic effects (induction and toxicity) caused by occupational exposure to styrene in the polyester industry. 1980 Scand J Work Environ Health pmid:6937826
Souqiyyeh MZ and Shaheen FA Attitude of physicians towards iron supplementation in hemodialysis patients treated with erythropoietin. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209438
Zolezzi M Intravenous Iron Saccharate Complex: Guidelines for its use in the Management of Anemia of Renal Disease. 2003 Apr-Jun Saudi J Kidney Dis Transpl pmid:18209437
Al-Mueilo SH Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. 2005 Apr-Jun Saudi J Kidney Dis Transpl pmid:18202490
Shaheen FA et al. Effect of intravenous iron saccharate on the requirements of erythropoietin in hemodialysis patients. 2002 Apr-Jun Saudi J Kidney Dis Transpl pmid:17660651
Swarnalatha G et al. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress. 2010 Saudi J Kidney Dis Transpl pmid:20814119
Haddad A et al. Use of iron sucrose in dialysis patients sensitive to iron dextran. 2009 Saudi J Kidney Dis Transpl pmid:19237805
Gupta A et al. Response to iron sucrose in dialysis patients sensitive to iron dextran. 2010 Saudi J Kidney Dis Transpl pmid:20587886
Smirne S et al. [Serum gamma-glutamyl-transpeptidase and urinary excretion of D-glucaric acid in epileptic patients treated with anticonvulsants]. 1974 Jul-Aug Riv Neurol pmid:4155805
Bergonzi P et al. [Long-term anticonvulsant therapy and calcium and phosphorus metabolism]. 1979 Jan-Feb Riv Neurol pmid:451400
Tutor-Crespo MJ et al. [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs]. 2002 Oct 16-31 Rev Neurol pmid:12402220
Chailleux E et al. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment]. 1980 Rev Fr Mal Respir pmid:7187065
Escartin Marin P et al. [Enzyme induction in alcoholic and cryptogenetic cirrhoses]. 1976 Rev Esp Enferm Apar Dig pmid:1257561
Gredilla E et al. [Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases]. 2009 Rev Esp Anestesiol Reanim pmid:20151526
Cançado RD et al. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia]. 2005 Nov-Dec Rev Assoc Med Bras (1992) pmid:16444338
Oredipe OA et al. Chemopreventative activity of dietary glucarate on azoxymethane-induced altered hepatic foci in rats. 1989 Res. Commun. Chem. Pathol. Pharmacol. pmid:2479062
Mezey E Increased urinary excretion of D-glucaric acid in alcoholism. 1976 Res. Commun. Chem. Pathol. Pharmacol. pmid:1005917
Harmankaya O and Eran A Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. 2002 Ren Fail pmid:12071600
Ozkurt S et al. Acute and subacute effects of EV iron sucrose on endothelial functions in hemodialysis patients. 2012 Ren Fail pmid:22017464
Solak Y et al. Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients. 2011 Ren Fail pmid:21401355
Anirban G et al. The comparative safety of various intravenous iron preparations in chronic kidney disease patients. 2008 Ren Fail pmid:18661414
Sav T et al. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? 2007 Ren Fail pmid:17497463
Guz G et al. Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose. 2004 Ren Fail pmid:15600258
Borchard G et al. Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies. 2012 Regul. Toxicol. Pharmacol. pmid:22951348
Toyokuni S Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. 2014 Redox Rep. pmid:24257681
Park BK et al. [Modification of the action of drugs by inhibition of their metabolism]. 1979 Recenti Prog Med pmid:42953
Beck IA Serendipity lost: a digressive account of an experience in the investigation of glucoronic acid metabolism in diabetes mellitus. 1991 R I Med J pmid:2047701
Pach J et al. New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. 2001 Prz. Lek. pmid:11450331
Fujihira E and Whitehouse MW Pathobiodynamics: reduced ascorbate excretion by rats with severe inflammation. 1977 Proc. Soc. Exp. Biol. Med. pmid:877135
Soldato PD and Meli A Studies on the mechanism of fat-free diet (FFD) protection against indomethacin-induced intestinal ulcers. 1978 Proc. Soc. Exp. Biol. Med. pmid:662870
Florey L The uptake of particulate matter by endothelial cells. 1967 Proc. R. Soc. Lond., B, Biol. Sci. pmid:24796034
Raman S et al. Evolution-guided optimization of biosynthetic pathways. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25453111
Abou-Issa HM et al. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene. 1988 Proc. Natl. Acad. Sci. U.S.A. pmid:2967969
Ferumoxytol: an intravenous iron, riskier than iron sucrose. 2013 Prescrire Int pmid:24171212
Cynke E [Parenteral iron replacement]. 1997 Praxis (Bern 1994) pmid:9312810
Murchison LE et al. Effects of anticonvulsants and inactivity on bone disease in epileptics. 1975 Postgrad Med J pmid:1161672
Zółtaszek R et al. [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. 2008 Postepy Hig Med Dosw (Online) pmid:18772850